We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. New-onset or relapse of uveitis after rapid spreading of COVID-19 infection in China and risk factor analysis for relapse

    Background

    The aim of this study was to report the clinical profile of new-onset and relapse of uveitis following rapid spreading of coronavirus...

    Kaixuan Wang, Jiawen Li, ... **aomin Zhang in BMC Ophthalmology
    Article Open access 26 April 2024
  2. Relapse rate and predictors of relapse after cessation of glucocorticoid maintenance therapy in type 1 autoimmune pancreatitis: a multicenter retrospective study

    Background

    Type 1 autoimmune pancreatitis responds well to glucocorticoid therapy with a high remission rate. Moreover, glucocorticoid maintenance...

    Yusuke Kiyoshita, Yasutaka Ishii, ... Shiro Oka in BMC Gastroenterology
    Article Open access 04 September 2023
  3. Differentiation of early relapse and late relapse in intermediate- and high-risk neuroblastoma with an 18F-FDG PET/CT-based radiomics nomogram

    Objectives

    To develop and validate an 18 F-FDG PET/CT-based radiomics nomogram for differentiating early relapse and late relapse of intermediate- and...

    Lijuan Feng, **lan Yao, ... Jigang Yang in Abdominal Radiology
    Article 05 February 2024
  4. (Dis)agreement of polymyalgia rheumatica relapse criteria, and prediction of relapse in a retrospective cohort

    Background

    To develop and assess a prediction model for polymyalgia rheumatica (PMR) relapse within the first year of glucocorticoid (GC) treatment.

    ...
    Thomas E. Bolhuis, Diane Marsman, ... Aatke van der Maas in BMC Rheumatology
    Article Open access 02 August 2022
  5. Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder

    Down syndrome regression disorder (DSRD) is a clinical symptom cluster consisting of neuropsychiatric regression without an identifiable cause. This...

    Jonathan D. Santoro, Noemi A. Spinazzi, ... Michael S. Rafii in Translational Psychiatry
    Article Open access 08 August 2023
  6. Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation

    Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the only curative treatment for myelofibrosis (MF). Relapse occurs in 10–30%...

    Sofia Oechsler, Nico Gagelmann, ... Nicolaus Kröger in Bone Marrow Transplantation
    Article Open access 06 February 2024
  7. Identifying relapse predictors in individual participant data with decision trees

    Background

    Depression is a highly common and recurrent condition. Predicting who is at most risk of relapse or recurrence can inform clinical...

    Lucas Böttcher, Josefien J. F. Breedvelt, ... Claudi L. H. Bockting in BMC Psychiatry
    Article Open access 13 November 2023
  8. Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system

    Schizophrenia is often characterized by recurring relapses, which are associated with a substantial clinical and economic burden. Early...

    Anne Rivelli, Veronica Fitzpatrick, ... Srikrishna Mylavarapu in Schizophrenia
    Article Open access 29 February 2024
  9. Computational markers of risky decision-making predict for relapse to alcohol

    Background

    Relapse remains the major challenge in treatment of alcohol use disorder (AUD). Aberrant decision-making has been found as important...

    Wei Yuan, Meng Chen, ... Tian-Gui Yu in European Archives of Psychiatry and Clinical Neuroscience
    Article 06 May 2023
  10. Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance

    Measurable residual disease (MRD) surveillance in acute myeloid leukemia (AML) may identify patients destined for relapse and thus provide the option...

    Nicholas McCarthy, Gege Gui, ... Sylvie Freeman in Leukemia
    Article Open access 18 June 2024
  11. Psychological interventions for the prevention of depression relapse: systematic review and network meta-analysis

    Depression is highly prevalent and easily relapses. Psychological interventions are effective for the prevention of depression relapse. This...

    Yurong Zhou, Defeng Zhao, ... Gang Zhu in Translational Psychiatry
    Article Open access 28 September 2023
  12. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders

    We aimed to identify diagnosis-specific/transdiagnostic/transoutcome multivariable candidate predictors (MCPs) of key outcomes in mental disorders....

    Marco Solmi, Samuele Cortese, ... Christoph U. Correll in Molecular Psychiatry
    Article Open access 13 November 2023
  13. Reduction of N-acetyl aspartate (NAA) in association with relapse in early-stage psychosis: a 7-Tesla MRS study

    Understanding the biological underpinning of relapse could improve the outcomes of patients with psychosis. Relapse is elicited by multiple...

    Marina Mihaljevic, Yu-Ho Chang, ... Akira Sawa in Schizophrenia
    Article Open access 01 March 2024
  14. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation

    Abstract

    Relapse after ASCT is an important factor affecting the long-term prognosis of patients with AL amyloidosis. However, the risk factors of...

    Yuanyuan Zhang, **zhou Guo, ... **anghua Huang in Bone Marrow Transplantation
    Article 26 December 2023
  15. Predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis in remission off medication

    The aim of this study was to evaluate the predictors of relapse in patients with oligoarticular juvenile idiopathic arthritis (oJIA) who achieved...

    Melike Mehveş Kaplan, Tuba Kurt, ... Banu Çelikel Acar in European Journal of Pediatrics
    Article 01 August 2023
  16. Lymphoma relapse 1 year or later after immunochemotherapy in DLBCL patients: clinical features and outcome

    Despite great advances in treatment, 30–40% of patients with DLBCL undergo relapses. Patients with a relapse within 1 year or beyond have a distinct...

    Hongyun Chen, **rong Zhao, ... Wei Zhang in Clinical and Experimental Medicine
    Article Open access 01 March 2024
  17. Efficacy of low-dose rituximab in minimal change disease and prevention of relapse

    Background

    Minimal change disease (MCD) is a major cause of nephrotic syndrome (NS) in children and a minority of adults. The higher tendency to...

    Jian Zhang, Hui Zhao, ... Zhigang Ma in BMC Nephrology
    Article Open access 26 April 2023
  18. Central Nervous System Relapse in T and NK cell Lymphomas

    Purpose of Review

    T and NK cell lymphomas are relatively rare and heterogeneous forms of non-Hodgkin lymphoma that are associated with high rates of...

    Eleanor P. Taranto, Stefan K. Barta, Rahul S. Bhansali in Current Hematologic Malignancy Reports
    Article 25 August 2023
  19. Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse

    The efficacy of high-dose methotrexate (HD-MTX) for central nervous system (CNS) relapse prophylaxis in patients with high-risk diffuse large B-cell...

    Masahiro Akimoto, Takuya Miyazaki, ... Hideaki Nakajima in International Journal of Hematology
    Article 17 January 2024
  20. Association between the time of initial relapse and subsequent relapses in patients with childhood-onset idiopathic nephrotic syndrome

    Background

    Nephrotic syndrome relapse within 6 months is a known risk factor for steroid-dependent nephrotic syndrome/frequently relapsing nephrotic...

    Yuta Inoki, Kentaro Nishi, ... Koichi Kamei in Pediatric Nephrology
    Article 25 January 2024
Did you find what you were looking for? Share feedback.